Pages that link to "Q55035699"
Jump to navigation
Jump to search
The following pages link to A long-term study of prognosis in monoclonal gammopathy of undetermined significance. (Q55035699):
Displaying 50 items.
- Prevalence of monoclonal gammopathy of undetermined significance: a systematic review (Q24597406) (← links)
- Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience (Q24597443) (← links)
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies (Q24607241) (← links)
- Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myeloma (Q24619589) (← links)
- Waldenström macroglobulinemia (Q24634076) (← links)
- Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma (Q24650785) (← links)
- Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease (Q24651269) (← links)
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study (Q24653006) (← links)
- Prevention of progression in monoclonal gammopathy of undetermined significance (Q24655581) (← links)
- Multiple myeloma (Q24655964) (← links)
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (Q24669898) (← links)
- C1 inhibitor deficiency: consensus document (Q24684165) (← links)
- Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance (Q26743454) (← links)
- MicroRNAs in multiple myeloma and related bone disease (Q26770478) (← links)
- Smoldering multiple myeloma (Q26863331) (← links)
- Imaging of multiple myeloma: Current concepts (Q26864616) (← links)
- Early lymphoid lesions: conceptual, diagnostic and clinical challenges (Q26996519) (← links)
- Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management (Q26998884) (← links)
- Recent advances in multiple myeloma: a Korean perspective (Q28074521) (← links)
- Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (Q28081570) (← links)
- Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group (Q28207984) (← links)
- Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation (Q28277343) (← links)
- Neurological manifestations of Waldenström macroglobulinemia (Q28295047) (← links)
- Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis (Q28386212) (← links)
- Age-related clonal hematopoiesis associated with adverse outcomes (Q28386602) (← links)
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia (Q28394721) (← links)
- Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk (Q28943395) (← links)
- Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management (Q30234567) (← links)
- Multiple myeloma epidemiology and survival: A unique malignancy (Q30239771) (← links)
- Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis (Q30316799) (← links)
- Multiple myeloma: the puzzle is finally completed (Q33362875) (← links)
- Multiple myeloma in 16 cats: a retrospective study (Q33369146) (← links)
- Immunophenotypic studies of monoclonal gammopathy of undetermined significance (Q33387979) (← links)
- Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents (Q33401759) (← links)
- Predictors of plasma cell disorders among African American patients: a community practice perspective (Q33412193) (← links)
- Hematological manifestations and complications of Gaucher disease (Q33427535) (← links)
- Concomitant multiple myeloma, gastric adenocarcinoma and Evan's syndrome in a patient presenting with anaemia (Q33437662) (← links)
- Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance (Q33479917) (← links)
- Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations (Q33628815) (← links)
- Polycomb target genes are silenced in multiple myeloma (Q33633898) (← links)
- The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network (Q33695919) (← links)
- Circulating serum free light chains as predictive markers of AIDS-related lymphoma (Q33710567) (← links)
- Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma (Q33744195) (← links)
- Osteoblastogenesis and tumor growth in myeloma (Q33768466) (← links)
- MicroRNA: important player in the pathobiology of multiple myeloma (Q33786861) (← links)
- Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells (Q33800466) (← links)
- Proteomic analysis of multiple myeloma: current status and future perspectives. (Q33807327) (← links)
- Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. (Q33827448) (← links)
- Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey (Q33875675) (← links)
- Aspergillus fumigatus scleritis associated with monoclonal gammopathy of undetermined significance (Q33899260) (← links)